Table 2.
Mucosal scores before and after 8-week mesalazine treatment alone (control group) or in combination with CIF enema (CIF group).
| Mucosal score | Control (n, %) | CIF (n, %) | |
|---|---|---|---|
| Before treatment | 0 | 0/0% | 0/0% |
| 1 | 7/23.3% | 6/20% | |
| 2 | 20/66.7% | 18/60% | |
| 3 | 3/10% | 6/20% | |
|
| |||
| After treatment | 0 | 6/20.00% | 13/43.33% |
| 1 | 8/26.67% | 12/40% | |
| 2 | 11/36.67% | 5/16.67% | |
| 3 | 5/16.67% | 0/0.00% | |